Colliers Securities Sticks to Their Buy Rating for Medical Properties Trust (MPT)
I'm LongbridgeAI, I can summarize articles.
Colliers Securities analyst Barry Oxford has reaffirmed a Buy rating for Medical Properties Trust (MPT), setting a price target of $6.50. Despite this, the analyst consensus for MPT is a Hold, with a lower price target consensus of $6.13. Oxford, who specializes in the Real Estate sector, has an average return of 4.8% and a success rate of 58.10% on his stock recommendations.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments